Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

艾滋病（AIDS，获得性免疫缺陷综合征）是一种危害极大的传染性疾病，由人类免疫缺陷病毒（HIV，也叫做艾滋病病毒）感染引起，于20世纪80年代首次被发现，一度被视为“绝症”。HIV主要有两种亚型，即HIV-1和HIV-2，相对来讲，HIV-1的复制能 ...

红枫湾APP：吉利德官方消息，6月30日，仅需每半年注射一次的、HIV-1暴露前预防（PrEP）长效抑制剂——Lenacapavir(来那帕韦)，在海南博鳌乐城国际医疗旅游先行区获批。 2024年的大型试验中证明，Lenacapavir在预防HIV感染方面几乎100%有效，《科学》杂志称其为2024年年度突破。 据悉，美国食品和药物管理局（FDA）于6月18日批准吉利德生产的Lenacapavir ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

近日，美国食品药品监督管理局（FDA）正式批准了由吉利德（Gilead）公司研发的全新艾滋病病毒（HIV）预防药物——来那卡帕韦（Lenacapavir）。这款 ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

距离lenacapavir用于HIV预防在美国获批仅8个工作日，这一国际领先的创新药物就在博鳌乐城实现了“全球同步”准入，以“零时差”完成从海外获批到 ...

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...

A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...

Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

The introduction of a revolutionary drug, Lenacapavir, is poised to alter the landscape of healthcare across sub-Saharan ...